| Unique ID issued by UMIN | UMIN000060951 |
|---|---|
| Receipt number | R000069573 |
| Scientific Title | Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon) |
| Date of disclosure of the study information | 2026/03/17 |
| Last modified on | 2026/03/16 18:38:41 |
Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon)
RECIPE-C Study
Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon)
RECIPE-C Study
| Japan |
Patients undergoing colonoscopy (for screening or diagnostic purposes)
| Gastroenterology |
Others
NO
1. To calculate the clinical equipotent dose ratio of RMZ to PRO in the same patients under opioid-free conditions.
2. To verify whether RMZ alone enables colonoscopy completion equivalent to PRO alone.
3. To evaluate differences in safety and quality of recovery.
PK,PD
Dose weight ratio (weight-adjusted total dose)
For each patient, the ratio of weight-adjusted doses calculated using the following formula (median and correlation coefficient):
Dose Weight Ratio (mg/kg) = Total Dose (mg) / Weight (kg)
Comparison of RMZ and PRO to derive the RMZ-to-PRO conversion ratio.
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Aged 20 years or older with opt-out consent obtained
Underwent colonoscopy for screening or diagnostic purposes with RMZ as the sedative
Had a colonoscopy under PRO monotherapy (opioid-free) at our institution within the past 2 years, completed by a single operator with a single scope to cecal intubation
Procedures performed by an expert endoscopist (board-certified gastroenterologist with >=2,000 colonoscopy experience) in both prior and current examinations
Change in ASA PS classification between prior and current examinations
History of colorectal surgery (except appendectomy)
Emergency endoscopy
Cases where procedural difficulty, invasiveness, or examination time was judged significantly different between prior and current examinations (e.g., therapeutic endoscopy such as ESD/EMR, severe adhesions, strictures)
Cold snare polypectomy for <=4 lesions is NOT excluded
Pregnant or possibly pregnant
Currently receiving opioids (including tramadol)
Judged inappropriate by the attending physician
100
| 1st name | Takeshi |
| Middle name | |
| Last name | Shimizu |
Sendai City Medical Center Sendai Open Hospital
Department of Gastroenterology
983-0824
5-22-1, Tsurugaya, Miyagino-ku, Sendai, Miyagi, Japan
022-252-1111
takeshi.shimizu@openhp.or.jp
| 1st name | Takeshi |
| Middle name | |
| Last name | Shimizu |
Sendai City Medical Center Sendai Open Hospital
Department of Gastroenterology
983-0824
Sendai City Medical Center Sendai Open Hospital
022-252-1111
takeshi.shimizu@openhp.or.jp
Sendai City Medical Center Sendai Open Hospital
self-funding
Self funding
Sendai City Medical Center Sendai Open Hospital
5-22-1, Tsurugaya, Miyagino-ku, Sendai, Miyagi, Japan
022-252-1111
masayuki.mori@openhp.or.jp
NO
| 2026 | Year | 03 | Month | 17 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 02 | Month | 19 | Day |
| 2026 | Year | 02 | Month | 19 | Day |
| 2026 | Year | 03 | Month | 02 | Day |
| 2026 | Year | 04 | Month | 30 | Day |
N/A
| 2026 | Year | 03 | Month | 16 | Day |
| 2026 | Year | 03 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069573